Paul Angulo - Concepedia

Author

Paul Angulo

Also Known As

Chi Istophcr Day, Inci Alican, M Navasa, P ANGULO, P Angulo, P. ANGULO, P. Angulo, PAUL ANGULO, Paola C. Angulo, Paul Angulo

239

Publications

35.5K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona University of Kentucky WinnMed Mayo Clinic in Florida

About

Paul Angulo is an author at Mayo Clinic specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	55	14.9K
2	Health Sciences	23	25	11.6K
3	Cell Biology	2	2	123
4	Allergy	1	1	23
5	Biochemistry	1	1	54

Paul Angulo

107

Publications

25.2K

Citations

H-Index

Page 1

	Year	Citations
The NAFLD fibrosis score Paul Angulo, Jason M. Hui, Giulio Marchesini, Hepatology	2007	3.1K
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study Leon A. Adams, James Lymp, Jenny St. Sauver, Gastroenterology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver Disease	2005	2.9K
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease Paul Angulo, David E. Kleiner, Sanne Dam‐Larsen, Gastroenterology Metabolic Associated SteatohepatitisFibrosisHepatologyLiver FibrosisNonalcoholic Fatty Liver Disease	2015	2.9K
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Ariel E. Feldstein, Ali Canbay, Paul Angulo, Gastroenterology ImmunologyCell DeathPathologyFatty Liver DiseaseCirrhosis	2003	1.1K
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies Leon A. Adams, Schuyler O. Sanderson, Keith D. Lindor, Journal of Hepatology Metabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseLiver Physiology	2004	907
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial Keith D. Lindor, Kris V. Kowdley, Jenny Heathcote, Hepatology PathologyUrsodeoxycholic AcidFatty Liver DiseaseNonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis	2004	727
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years Ariel E. Feldstein, Phunchai Charatcharoenwitthaya, Sombat Treeprasertsuk, Gut	2009	721
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis Kelly W. Burak, Paul Angulo, Tousif M. Pasha, The American Journal of Gastroenterology GastroenterologyPathologyPrimary Biliary CirrhosisCholangiopathiesAutoimmune Liver Disease	2004	549
Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease Paul Angulo, Elisabetta Bugianesi, Einar S. Björnsson, Gastroenterology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisBody CompositionHepatology	2013	506
Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis Aldo J. Montaño‐Loza, Paul Angulo, Judith Meza–Junco, Journal of Cachexia Sarcopenia and Muscle	2015	492

Page 1